Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jul 9;53(3):1043–1054. doi: 10.3892/ijo.2018.4477

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Wang et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Biological effects of NT21MP and si-MYD88 on PR cells. (A) Effects of NT21MP and si-MYD88 on cell migration and invasion were measured using a wound-healing assay. (B) Effects of NT21MP and si-MYD88 on cell cycle were analyzed using PI staining and flow cytometry. (C) Effects of NT21MP and si-MYD88 on cell apoptosis were evaluated using Annexin V/PI staining and flow cytometry. (D) Reverse transcription-quantitative polymerase chain reaction analysis was used to detect the effect of NT21MP and si-MYD88 on the mRNA levels of target genes, cell cycle, and apoptosis-related factors. (E) Western blot analysis results of the protein level of target gene, cell cycle, and apoptosis-related factors in PR cells were consistent with the mRNA results. The data are presented as the mean ± standard deviation of three independent experiments. ^@@@P<0.001, compared with the control group; ^***P<0.001, compared with SDF-1α treatment; #P<0.05, ^##P<0.01 and ^###P<0.001, compared with S + NT21MP treatment; ^∆∆P<0.01 and ^∆∆∆P<0.001, compared with S + si-MYD88 treatment. NT21MP; 21-residue peptide derived from viral macrophage inflammatory protein II; S/SDF-1α, stromal cell-derived factor-1α; NT, NT21MP; PR, paclitaxel-resistant; MYD88, myeloid differentiation primary response gene 88; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein; PI, propidium iodide; si, small interfering RNA.

Biological effects of NT21MP and si-MYD88 on PR cells. (A) Effects of NT21MP and si-MYD88 on cell migration and invasion were measured using a wound-healing assay. (B) Effects of NT21MP and si-MYD88 on cell cycle were analyzed using PI staining and flow cytometry. (C) Effects of NT21MP and si-MYD88 on cell apoptosis were evaluated using Annexin V/PI staining and flow cytometry. (D) Reverse transcription-quantitative polymerase chain reaction analysis was used to detect the effect of NT21MP and si-MYD88 on the mRNA levels of target genes, cell cycle, and apoptosis-related factors. (E) Western blot analysis results of the protein level of target gene, cell cycle, and apoptosis-related factors in PR cells were consistent with the mRNA results. The data are presented as the mean ± standard deviation of three independent experiments. ^@@@P<0.001, compared with the control group; ^***P<0.001, compared with SDF-1α treatment; #P<0.05, ^##P<0.01 and ^###P<0.001, compared with S + NT21MP treatment; ^∆∆P<0.01 and ^∆∆∆P<0.001, compared with S + si-MYD88 treatment. NT21MP; 21-residue peptide derived from viral macrophage inflammatory protein II; S/SDF-1α, stromal cell-derived factor-1α; NT, NT21MP; PR, paclitaxel-resistant; MYD88, myeloid differentiation primary response gene 88; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein; PI, propidium iodide; si, small interfering RNA.